A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...

Evaluation of the drug by Canadian regulatory authorities is under way. Paladin Labs will take over distribution of BTG’s treatment for digoxin toxicity or overdose in Canada. DigiFab™ is currently ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

Cyanide binds to the ferric ion on cytochrome oxidase and abruptly halts the electron transport chain and aerobic respiration, producing profound toxic effects. Cyanide also preferentially binds to ...

Digoxin use among patients who are on hemodialysis (HD) may increase their risk of death, especially if they have low predialysis potassium levels, a study showed. HD patients who used digoxin had a ...

University at Buffalo researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin.

Foxglove, a flowering plant long feared for its toxicity, became an unlikely source of a widely studied heart drug. Digoxin, a cardiac glycoside associated in modern medicine with Digitalis species ...

People prescribed digoxin are being urged by the NHS to speak to their doctor if they experience two common side effects. Digoxin is a cardiac gylocoside medicine that is regulary prescribed to reat a ...